CoChat

Tempol, a Superoxide Dismutase Mimetic Agent, Inhibits Superoxide Anion-Induced Inflammatory Pain in Mice

Open access
Bernardy, Catia C. F., Zarpelon, Ana C., Pinho-Ribeiro, Felipe A., Calixto-Campos, Cássia, Carvalho, Thacyana T., Fattori, Victor, Borghi, Sergio M., Casagrande, Rubia, Verri, Waldiceu A. · 2017 · BioMed Research International

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

The present study evaluated the anti-inflammatory and analgesic effects of the superoxide dismutase mimetic agent tempol in superoxide anion-induced pain and inflammation. Mice were treated intraperitoneally with tempol (10–100 mg/kg) 40 min before the intraplantar injection of a superoxide anion donor, potassium superoxide (KO 2, 30 μ g). Mechanical hyperalgesia and thermal hyperalgesia, paw edema, and mRNA expression of peripheral and spinal cord mediators involved in inflammatory pain, TNF α, IL-1 β, IL-10, COX-2, preproET-1, gp91phox, Nrf2, GFAP, and Iba-1, were evaluated. Peripheral and spinal cord reductions of antioxidant defenses and superoxide anion were also assessed. Tempol reduced KO 2-induced mechanical hyperalgesia and thermal hyperalgesia and paw edema. The increased mRNA expression of the evaluated mediators and oxidative stress in the paw skin and spinal cord and increased mRNA expression of glial markers in the spinal cord induced by KO 2 were successfully inhibited by tempol. KO 2-induced reduction in Nrf2 mRNA expression in paw skin and spinal cord was also reverted by tempol. Corroborating the effect of tempol in the KO 2 model, tempol also inhibited carrageenan and CFA inflammatory hyperalgesia. The present study demonstrates that tempol inhibits superoxide anion-induced molecular and behavioral alterations, indicating that tempol deserves further preclinical studies as a promising analgesic and anti-inflammatory molecule for the treatment of inflammatory pain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2017/9584819

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Tempol inhibits KO2-induced hyperalgesia and paw edema. Mice were treated with tempol (10–100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Nociceptive thresholds to mechanical (a) and thermal (b) stimuli as well as paw edema (c) were measured 1–5 h after KO2 injection. Results are expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle; ∗∗p < 0.05 versus KO2 + tempol 10 mg/kg; ##p < 0.05 versus KO2 + tempol 30 mg/kg (ANOVA followed by Tukey's t-test)].
Figure 1 Tempol inhibits KO2-induced hyperalgesia and paw edema. Mice were treated with tempol (10–100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Nociceptive thresholds to mechanical (a) and thermal (b) stimuli as well as paw edema (c) were measured 1–5 h after KO2 injection. Results are expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle; ∗∗p < 0.05 versus KO2 + tempol 10 mg/kg; ##p < 0.05 versus KO2 + tempol 30 mg/kg (ANOVA followed by Tukey's t-test)].CC BY · PubMed Central
Figure 2 Tempol inhibits KO2-induced TNFα, IL-1β, and IL-10 mRNA expression in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2-stimulus and TNFα ((a) and (b)), IL-1β ((c) and (d)), and IL-10 ((e) and (f)) mRNA expressions were evaluated by RT-qPCR. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].
Figure 2 Tempol inhibits KO2-induced TNFα, IL-1β, and IL-10 mRNA expression in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2-stimulus and TNFα ((a) and (b)), IL-1β ((c) and (d)), and IL-10 ((e) and (f)) mRNA expressions were evaluated by RT-qPCR. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].CC BY · PubMed Central
Figure 3 Tempol inhibits KO2-induced COX-2 and preproET-1 mRNA expressions in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2-stimulus and COX-2 ((a) and (b)) and preproET-1 ((c) and (d)) mRNA expressions were evaluated by RT-qPCR. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].
Figure 3 Tempol inhibits KO2-induced COX-2 and preproET-1 mRNA expressions in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2-stimulus and COX-2 ((a) and (b)) and preproET-1 ((c) and (d)) mRNA expressions were evaluated by RT-qPCR. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].CC BY · PubMed Central
Figure 4 Tempol inhibits KO2-induced depletion of antioxidant capacity in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2-stimulus and the oxidant capacity was evaluated by FRAP ((a) and (b)), ABTS ((c) and (d)), and GSH ((e) and (f)) assays. Results are expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].
Figure 4 Tempol inhibits KO2-induced depletion of antioxidant capacity in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2-stimulus and the oxidant capacity was evaluated by FRAP ((a) and (b)), ABTS ((c) and (d)), and GSH ((e) and (f)) assays. Results are expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].CC BY · PubMed Central
Figure 5 Tempol inhibits KO2-induced oxidative stress in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2 injection to evaluate gp91phox mRNA expression ((a) and (b)) and NBT reduction (superoxide anion production assay, (c) and (d)) by qPCR and colorimetric assay, respectively. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].
Figure 5 Tempol inhibits KO2-induced oxidative stress in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2 injection to evaluate gp91phox mRNA expression ((a) and (b)) and NBT reduction (superoxide anion production assay, (c) and (d)) by qPCR and colorimetric assay, respectively. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].CC BY · PubMed Central
Figure 6 Tempol inhibits KO2-induced decrease of Nrf2 mRNA expression in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2 injection and Nrf2 mRNA expression was evaluated by qPCR. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].
Figure 6 Tempol inhibits KO2-induced decrease of Nrf2 mRNA expression in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2 injection and Nrf2 mRNA expression was evaluated by qPCR. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].CC BY · PubMed Central
Figure 7 Tempol inhibits KO2-induced astrocytes and microglia activation in the spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Spinal cord samples were collected 3 h after KO2 injection and GFAP (a) and Iba-1 (b) mRNA expressions were evaluated by RT-qPCR. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].
Figure 7 Tempol inhibits KO2-induced astrocytes and microglia activation in the spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Spinal cord samples were collected 3 h after KO2 injection and GFAP (a) and Iba-1 (b) mRNA expressions were evaluated by RT-qPCR. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].CC BY · PubMed Central
Figure 8 Tempol inhibits carrageenan and complete Freund's adjuvant- (CFA-) induced hyperalgesia. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before carrageenan or CFA intraplantar injection. Nociceptive thresholds to mechanical and thermal stimuli were measured 1–5 h after carrageenan injection (panels (a) and (b), resp.) and 1–7 days after CFA injection (panels (c) and (d), resp.). Results are expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus carrageenan + vehicle for panels (a)-(b) and versus CFA + vehicle for panels (c)-(d) (ANOVA followed by Tukey's t-test)].
Figure 8 Tempol inhibits carrageenan and complete Freund's adjuvant- (CFA-) induced hyperalgesia. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before carrageenan or CFA intraplantar injection. Nociceptive thresholds to mechanical and thermal stimuli were measured 1–5 h after carrageenan injection (panels (a) and (b), resp.) and 1–7 days after CFA injection (panels (c) and (d), resp.). Results are expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus carrageenan + vehicle for panels (a)-(b) and versus CFA + vehicle for panels (c)-(d) (ANOVA followed by Tukey's t-test)].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 4

  1. 2016, Frontiers in Pharmacology, 7, 532
  2. 1898, Journal of Biological Chemistry, 264, 11131
  3. 2016, PLoS ONE, 11
  4. 2016, PLoS ONE, 11

Cited by

See all 46

Metadata

Authors
Bernardy, C. C. F., Zarpelon, A. C., Pinho-Ribeiro, F. A., Calixto-Campos, C., Carvalho, T. T., Fattori, V., Borghi, S. M., Casagrande, R., & Verri, W. A.
Affiliations
  • Department of Nursing, Health Science Centre, State University of Londrina, Londrina, PR, Brazil
  • Universidade Estadual de Londrina (BR)
  • Department of Pathology, Biological Science Centre, State University of Londrina, Londrina, PR, Brazil
  • Department of Pharmaceutical Sciences, Health Science Centre, State University of Londrina, Londrina, PR, Brazil
Venue
BioMed Research International
Publisher
Wiley
Published
2017
Volume
2017
Pages
1-15
ISSN
  • 1110-7243 (ISSN-L)
  • 2314-6133
  • 2314-6141
OpenAlex
W2613348303
Cited by
40
References
52
Citations by year
2026: 2 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 9 · 2020: 5 · 2019: 8 · 2018: 4 · 2017: 1
FWCI
3.64
Type
journal article
Language
en
Open access
Locations
  • BioMed Research International (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Ministério da Ciência Tecnologia e Inovação
  • Secretaria da Ciência, Tecnologia e Ensino Superior
  • Fundação Araucária
  • Parana State Government
Topics
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Keywords
tempol, superoxide dismutase mimetic, inflammatory pain, superoxide, potassium superoxide, oxidative stress, Nrf2, mechanical hyperalgesia, thermal hyperalgesia, paw edema, glial activation, TNF-α, IL-1β, IL-10, cyclooxygenase-2, endothelin-1, gp91phox, carrageenan-induced inflammation, complete Freund's adjuvant, analgesics, anti-inflammatory agents
MeSH terms
NADPH Oxidase 2, Animals, Calcium-Binding Proteins, Cyclic N-Oxides, Glial Fibrillary Acidic Protein, Male, Mice, Inbred BALB C, Microfilament Proteins, Pain, Spin Labels, Superoxides, Superoxide Dismutase, Cytokines, Biomimetic Materials, NF-E2-Related Factor 2, Mice, Cyclooxygenase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.